Key result
Highest hs-cTnT and NT-proBNP levels linked to excessive decline in global cognitive scores.
Why the study?
hs-cTnT and NT-proBNP are linked to increased stroke risk and possibly cognitive decline, but few prospective studies with extended follow-up exist.
Are baseline levels of hs-cTnT and NT-proBNP associated with 15-year cognitive decline in community-dwelling adults?
Cohort (n=9,114)
Yes
Are baseline levels of hs-cTnT and NT-proBNP associated with 15-year cognitive decline in community-dwelling adults?
Effect estimate: Difference -0.34 (95% CI -0.63 to -0.04)
Elevated baseline levels of hs-cTnT and NT-proBNP individually were not robustly associated with 15-year cognitive decline, but their combination suggested an association in post hoc analysis.
Combined hs-cTnT and NT-proBNP elevation was associated with cognitive decline; hypothesis-generating and requires prospective confirmation before clinical use.
OBJECTIVES Cardiac troponin T, measured using a high‐sensitive assay (hs‐cTnT), and N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) are associated with increased stroke risk and perhaps with cognitive decline. However, few well‐designed prospective studies with extended follow‐up have been conducted. We aimed to estimate the association of hs‐cTnT and NT‐proBNP with 15‐year cognitive change in the Atherosclerosis Risk in Communities (ARIC) study. DESIGN Prospective cohort study. SETTING Four US communities. PARTICIPANTS A total of 9114 and 9108 participants from the Atherosclerosis Risk in Communities study for analyses of hs‐cTnT and NT‐proBNP, respectively. MEASUREMENTS We examined association of hs‐cTnT and NT‐proBNP with 15‐year change (1996‐1998 to 2011‐2013) in three cognitive tests of executive function (Digit Symbol Substitution Test), verbal learning memory (Delayed Word Recall Test), and semantic fluency (Word Fluency Test), and an overall score combining the three tests using multivariable linear mixed effect models. We conducted several sensitivity analyses including multiple imputations to address bias due to missing data and attrition, and we compared associations within groups combining hs‐cTnT and NT‐proBNP into a three‐level categorical variable. RESULTS At baseline (1996‐1998), mean age was 63.4 (standard deviation [SD] = 5.7) years; 56.4% were women, and 17.5% were black. The hs‐cTnT at baseline was not associated with cognitive change in any measure. Some evidence indicated accelerated decline in verbal learning and memory when comparing those in the highest with the lowest NT‐proBNP quintiles; however, this association was not replicated when considering clinically relevant cutoffs or deciles of exposure in survivors. Sensitivity analyses were consistent with our primary analyses. There was little evidence to support effect modification by any considered factors. People with highest levels of both biomarkers had excessive decline in global z scores vs people with lowest levels (−.34; 95% confidence interval = −.63 to −.04). CONCLUSION Markers of myocardial injury and stretch were not associated with cognitive decline following 15 years among survivors, but when combined together they were suggestive in post hoc analysis. Whether this represents targets of intervention should be examined in the future. J Am Geriatr Soc 67:2353–2361, 2019
No takes yet. Share an insight, caveat, or question.
Pokharel et al. (2019) conducted a cohort in Cognitive decline (n=9,114). hs-cTnT and NT-proBNP vs. Lowest levels of biomarkers was evaluated on 15-year change in three cognitive tests and an overall score (Difference -0.34, 95% CI -0.63 to -0.04). Participants with the highest levels of both hs-cTnT and NT-proBNP had excessive decline in global cognitive z scores compared to those with the lowest levels (-0.34; 95% CI -0.63 to -0.04).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: